MAYNE PHARMA GROUP LIMITEDMAYNE PHARMA GROUP LIMITEDMAYNE PHARMA GROUP LIMITED

MAYNE PHARMA GROUP LIMITED

No trades
See on Supercharts

Price target

6.090.000.00%
The 2 analysts offering 1 year price forecasts for MYX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to MYX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


MYX EPS for the last quarter is 0.00 AUD despite the estimation of −0.22 AUD. In the next quarter EPS is expected to reach −0.14 AUD. Track more of MAYNE PHARMA GROUP LIMITED financials and stay on top of what is up with the company.
In the next quarter MAYNE PHARMA GROUP LIMITED revenue is expected to reach ‪211.35 M‬ AUD. Check out MAYNE PHARMA GROUP LIMITED revenue and earnings and make informed decisions.
According to analysts, MYX price target is 6.09 AUD with a max estimate of 6.25 AUD and a min estimate of 5.93 AUD. Check if this forecast comes true in a year, meanwhile watch MAYNE PHARMA GROUP LIMITED stock price chart and keep track of the current situation with MYX news and stock market news.